Skip to content

Heart fatty acid binding protein combined with inflammatory factors and prognosis of sepsis related research

Heart fatty acid binding protein combined with inflammatory factors and prognosis of sepsis related research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ODC-15007445
Enrollment
Unknown
Registered
2015-11-20
Start date
2014-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Case series:no

Sponsors

The first Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Sepsis (1) Fever (>38.3 degree C), Hypothermia (core temperature90 min-1 or more than two SD above the normal value for age; Tachypnea; Altered mental status; Significant edema or positive fluid balance (>20 mL/kg over 24 h); Hyperglycemia (plasma glucose>140 mg/dL or 7.7 mmol/L) in the absence of diabetes; (2) Inflammatory variables:Leukocytosis (WBC count>12,000 lL-1), Leukopenia (WBC count40 mmHg in adults, or less than two SD below normal for age; (4) Organ dysfunction variables: Arterial hypoxemia (PaO2/FiO2=0.5 mg/dL or 44.2 lmol/L; Coagulation abnormalities (INR>1.5 or aPTT>60 s); Ileus (absent bowel sounds); Thrombocytopenia (platelet count4 mg/dL or 70 lmol/L); (5) Tissue perfusion variables: Hyperlactatemia (>1 mmol/L), Decreased capillary refill or mottling. Severe sepsis (1) Lactate above upper limits laboratory normal; (2) Urine output2.0 mg/dL (176.8 lmol/L); (5) Bilirubin>2 mg/dL (34.2 lmol/L); (6) Platelet count1.5). Septic shock: (1) Systolic blood pressure 40mmHg at least 1h, or dependent on infusion and drugs to maintain blood pressure, mean arterial pressure 2s; (3) cold limbs or piebald skin; (4) lactic acidosis; (5) decreased urine output (urine output <0.5 ml/kg/h, for at least two hours, even if given adequate fluid resuscitation).

Exclusion criteria

Exclusion criteria: (1) Who do not want to participate in this experimenter or their families; (2) Age <18 years; (3) A history of left ventricular dysfunction, dilated cardiomyopathy, acute coronary syndrome, acute or chronic heart valve disease, acute or chronic renal insufficiency, defibrillation, direct current cardioversion, chest trauma, chest compressions, thoracic incision, myocardial damage, cardiogenic shock, hemorrhagic shock, acute or chronic heart failure), patients with muscle injury.

Design outcomes

Secondary

MeasureTime frame
Hematocrit;Potassium;Sodium;28 days Mortality;Blood platelet;Lactate;PH;PaO2;left atrial diameter (LA);Left ventricular internal diameter (LV);right atrial diameter (RA);Right ventricular internal diameter (RV);Ejection Fraction;cardiac output;stroke volume;

Primary

MeasureTime frame
Heart fatty acid binding protein;BNP;Troponin;Creatinine;APACH-II score;IL-6;Creatine kinase;Creatine kinase isoenzyme;Procalcitonin;High-sensitivity C-reactive protein;

Countries

China

Contacts

Public ContactYang Jianzhong
yjz6542@126.com+86 13699361888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026